Navigation Links
Caris Life Sciences Adds Next-Generation Sequencing to Enhance Evidence-Based Tumor Profiling Service for Cancer Patients
Date:1/28/2013

atient cases, averaging more than 25 possible clinically-actionable biomarkers per patient.

"Evaluating DNA only doesn't address the true complexity of the biology driving the cancer. It is essential to consider the significant impact of RNA and downstream alterations of the proteins involved in each patient's disease," said David D. Halbert , Chairman and Chief Executive Officer of Caris Life Sciences. "It's imperative to perform a holistic and comprehensive analysis on a tumor, especially the proteins, which are the active agents.  Anything less does a disservice to the treating physician and could potentially put a patient at risk."

"Integrating next-generation sequencing further demonstrates our commitment to continually evolve with emerging science to provide our physicians with an unmatched comprehensive tumor profiling service," said Tom Spalding , Senior Vice President & Group Head, Oncology, Caris Life Sciences. "As a result of this comprehensive approach, we believe we can provide significantly greater clinical utility than services that solely rely on single technology platforms. For example, NGS analysis alone would not provide oncologists with key insights into some of the most commonly used companion diagnostics, as FDA-approved labeling requires the use of specific and varied profiling technologies."

NGS will power the mutational analyses performed in the company's Select and Comprehensive profiles, enabling rapid examination and broader detection of somatic mutations across hundreds of hotspots in the cancer genome. Additionally, this critical technology enables the inclusion of emerging biomarkers that may have potential clinical or research applications. The addition of these emerging biomarkers will further enhance the utility of the Caris Registry®, which houses critical data on biomarker, drug and patient outcom
'/>"/>

SOURCE Caris Life Sciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Caris Sponsors CancerCare Connect Education Workshop on Molecular Profiling in the Treatment of Breast Cancer
2. Caris Life Sciences mejora la evaluación por perfil molecular con los biomarcadores ROS1 y MGMT-metilación
3. Caris Life Sciences Enhances Molecular Profiling Service with Addition of ROS1 and MGMT-Methylation Biomarkers
4. Multi-Axes Cartesian Robotic Platform for Life Sciences Automation
5. Indiana’s Life Sciences Industry Economic Impact Tops $50 billion
6. GlycoCheck Announces Partnership in the United States with Vascular Health Sciences
7. Atharva Lifesciences Consulting Releases the Biggest Ever Compilation of Science Funding Sources for India
8. SeraCare Life Sciences Divests Biorepository Business
9. SeraCare Life Sciences Sharpens Focus on Diagnostics Industry
10. Breakthrough Book From GLS Sciences Ends Blood Sugar Abuse in Time For The Holidays
11. 1DegreeBio Expands its Product Review Platform Across Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2014)... , July 17, 2014  Vanda Pharmaceuticals Inc. ... focused on the development and commercialization of products for ... it will release results for the second quarter of ... opens. The Company will host a ... 7, 2014, during which Vanda management will discuss the ...
(Date:7/17/2014)...  Prana Biotechnology (NASDAQ: PRAN ; ASX: ... development program for Alzheimer,s disease. Professor ... Mental Health, The University of Melbourne, will today include ... in his presentation at the Alzheimer,s Association International Conference ... The presentation is entitled: "How to change and ...
(Date:7/17/2014)... all know, some optical devices can only work with ... polarizer is necessary to shift the polarization direction of ... half-wave plate, which constructed out of a birefringent material ... half-wave plate depends on the thickness of the crystal, ... a half-wave plate is difficulty to integrate on circuits. ...
(Date:7/17/2014)... , July 17, 2014  Exelixis, Inc. (Nasdaq: ... company. EXEL developed two cancer treatments cabozantinib (Cabo, Cometriq) ... active component. The company has a partnership with Roche ... to earn approval in the treatment of melanoma by ... week. Cabo is marketed and distributed in the U.S. ...
Breaking Biology Technology:Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 2Prana Alzheimer's disease Development Program update 2Prana Alzheimer's disease Development Program update 3Prana Alzheimer's disease Development Program update 4Prana Alzheimer's disease Development Program update 5Exelixis, Inc., Analyst Report; The Upside Potential is Worth the Risk by BrokerBank Securities, Inc. 2
... Inc. (TSX:SDI), a company developing products for the ... International Symposium on Intensive Care and Emergency Medicine ... feature a key scientific symposium entitled, "The Role ... thought leaders in the field of sepsis. Presentations ...
... - Up to $50 Million Potential Milestones plus Double ... Host Conference Call at 11:00 a.m. ET Today - ... Amex: NBY ), a mid-stage biopharmaceutical company ... of a wide range of infections without causing resistance, ...
... 23, 2009 Reston, Va. The American Institute ... for Composites (ASC) congratulate the winners of the inaugural ... Distinguished Professor of Mechanical and Aerospace Engineering at the ... A. Armstrong Distinguished Professor of Aeronautical and Astronautical Engineering ...
Cached Biology Technology:Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin 2NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 2NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 3NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 4NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 5NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions 6Professors Raphael Haftka and C. T. Sun to receive AIAA-ASC James H. Starnes Jr. Award 2
(Date:7/21/2014)... and think, "Of course! Why didn,t I think of ... own invention, sparking ideas and building possibilities. This type ... Station Program Science Office,s new 15-book Researcher,s Guide Series. ... in orbit, their mental wheels may begin to speed ... propose new research and potentially make discoveries that they ...
(Date:7/21/2014)... Lgar,s team at the INRS nergie Matriaux Tlcommunications ... a spatial and temporal resolution greatly exceeding that ... a femtosecond laser source to shoot a molecular ... vinylidene. An article presenting the advancement was recently ... . , "The approach we developed combines ...
(Date:7/21/2014)... -- Why does the word "dog" have meaning? If ... friend understand you? , Kansas State University philosopher Elliott ... his latest research, which focuses on long-standing philosophical questions ... two other philosophers and a mathematician are collaborating to ... acquires meaning. , "If I order a cappuccino at ...
Breaking Biology News(10 mins):International Space Station researcher guides aim to maximize science 2International Space Station researcher guides aim to maximize science 3International Space Station researcher guides aim to maximize science 4Philosopher uses game theory to understand how words, actions acquire meaning 2
... [Brown University] A computerized epidemiological model of the spread ... California in 2005 successfully predicted where 81.6 percent of human ... where the risk of infection turned out to be 39 ... research. The DYCAST software used in those predictions is now ...
... cells is a well-oiled machine with tiny protein motors hauling ... molecular motors are responsible for a variety of critical transport ... can put themselves into "energy save mode" to conserve cellular ... the cell, and when. A new study ...
... may not sound very glamorous, a new method of ... news for both confined animal operations and environmental groups, ... The method uses gas-permeable membrane technology that tests have ... in liquid manure in 20 days. The removed ammonium ...
Cached Biology News:Software predicted risk in California West Nile virus epidemic 2Carnegie Mellon scientists discover how molecular motors go into 'energy save mode' 2Carnegie Mellon scientists discover how molecular motors go into 'energy save mode' 3New technology could capture ammonia from liquid manure 2New technology could capture ammonia from liquid manure 3
... fast and reliable automation for today's ... development laboratories. Staccato Mini-Workstations offer the ... basic liquid handling and material management ... either Caliper's time proven CLARA™ assay ...
Experion StdSens chips are the microfluidic chips used to perform standard-sensitivity RNA analysis (nanogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to...
... If particles in the submicron range ... development process, measurement and control of particle ... an analyzer that can reliably detect the ... The N5 Submicron Particle Size Analyzer uses ...
...
Biology Products: